inshorts

Centre proposes approval before antimicrobial manufacturing licences

India's health ministry has proposed amending the New Drugs and Clinical Trials Rules, 2019, requiring antimicrobial manufacturers to obtain Central Licensing Authority approval before applying for state manufacturing licences. The draft notification aims to strengthen regulatory oversight, ensure product quality, safety, and efficacy, and combat growing antimicrobial resistance. Stakeholders have 30 days to submit objections.